Eyepoint Pharmaceuticals Inc Working Capital to Net Assets Ratio

Latest as of September 2025: 92.9%

Eyepoint Pharmaceuticals Inc working capital to net assets ratio. Eyepoint Pharmaceuticals Inc (EYPT) has a Working Capital to Net Assets ratio of 92.9% as of September 2025. Working capital of $186.01 Million (current assets of $216.11 Million minus current liabilities of $30.09 Million) is measured against net assets of $200.18 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check EYPT tangible net worth ratio to evaluate the tangible quality of the company's equity base.

WC/NA Ratio

92.9%
Working Capital / Net Assets

Working Capital

$186.01 Million
USD

Current Assets

$216.11 Million
USD

Current Liabilities

$30.09 Million
USD

Working Capital to Net Assets Ratio of Eyepoint Pharmaceuticals Inc (2000–2024)

Working capital to net assets ratio of Eyepoint Pharmaceuticals Inc from 2000 to 2024. This chart shows how Eyepoint Pharmaceuticals Inc's Working Capital to Net Assets ratio has evolved across 24 annual periods from 2000 to 2024. As of September 2025, the ratio stands at 92.9%, reflecting working capital of $186.01 Million against net assets of $200.18 Million USD. See EYPT days of operational coverage to measure how many days the company can operate on defensive assets alone.

Eyepoint Pharmaceuticals Inc Working Capital to Net Assets Ratio by Year (2000–2024)

Eyepoint Pharmaceuticals Inc working capital to net assets ratio by year from 2000 to 2024. The table below presents the year-by-year Working Capital to Net Assets ratio for Eyepoint Pharmaceuticals Inc from 2000 to 2024, covering 24 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see EYPT current and non-current assets.

Year WC/NA Ratio Working Capital (USD) Net Assets Current Assets Current Liabilities Change (pp)
2024 99.3% $334.26 Million $336.50 Million $383.31 Million $49.05 Million ▼ -6.4 pp
2023 105.7% $281.54 Million $266.32 Million $344.80 Million $63.26 Million ▼ -37.8 pp
2022 143.5% $138.27 Million $96.37 Million $172.81 Million $34.54 Million ▲ +27.4 pp
2021 116.1% $214.09 Million $184.38 Million $237.75 Million $23.66 Million ▼ -144.0 pp
2020 260.1% $48.23 Million $18.54 Million $63.12 Million $14.89 Million ▼ -102.4 pp
2019 362.5% $30.20 Million $8.33 Million $41.72 Million $11.52 Million ▲ +206.4 pp
2018 156.1% $18.25 Million $11.69 Million $39.91 Million $21.66 Million ▲ +62.8 pp
2017 93.4% $12.45 Million $13.34 Million $17.74 Million $5.29 Million ▼ -25.7 pp
2016 119.1% $24.87 Million $20.88 Million $29.96 Million $5.09 Million ▲ +5.7 pp
2015 113.4% $26.49 Million $23.37 Million $29.84 Million $3.35 Million ▼ -2.0 pp
2014 115.4% $17.22 Million $14.92 Million $19.34 Million $2.13 Million ▼ -3.6 pp
2013 119.0% $9.16 Million $7.70 Million $12.46 Million $3.30 Million ▲ +25.2 pp
2012 93.7% $12.78 Million $13.64 Million $15.96 Million $3.18 Million ▲ +39.4 pp
2011 54.3% $20.33 Million $37.43 Million $25.37 Million $5.03 Million ▲ +5.6 pp
2010 48.7% $16.10 Million $33.04 Million $19.03 Million $2.93 Million ▲ +51.2 pp
2009 -2.5% $-592.00K $23.54 Million $8.13 Million $8.72 Million ▲ +7.6 pp
2008 -10.1% $-2.20 Million $21.79 Million $10.91 Million $13.11 Million ▲ +8.7 pp
2007 -18.8% $-12.40 Million $65.91 Million $5.69 Million $18.09 Million ▲ +8.0 pp
2006 -26.8% $-17.72 Million $66.20 Million $6.16 Million $23.89 Million ▼ -41.6 pp
2005 14.8% $9.02 Million $60.74 Million $10.57 Million $1.56 Million ▲ +0.0 pp
2004 14.8% $9.02 Million $60.74 Million $10.57 Million $1.56 Million ▼ -62.7 pp
2003 77.5% $20.70 Million $26.70 Million $22.05 Million $1.35 Million ▲ +70.6 pp
2002 6.9% $291.30K $4.23 Million $879.68K $588.38K ▼ -27.8 pp
2000 34.7% $1.59 Million $4.57 Million $1.73 Million $145.74K —
pp = percentage points